8 Jun 2011

Nanjing to build biomedical innovation platform

 Inside contemporary years, with the Life Sciences Innovation Park, Jiangsu, Nanjing Biomedical Research Institute to set up a run of development platforms, the Nanjing Yangtze River Delta region began to build the biggest "trough." The then 3 years, the inhabitant, local, public, constituency four 10.0 billion establishment investment of the funds will be frankly contributing to handbook various types of social hub invested 100 billion yuan or more, support a digit of strong innovation skill and bio-pharmaceutical enterprises own intellectual property civil rights growing speedily. 2013,10-Hydroxydecanoic Acid fee , Nanjing will realize super-scale bio-pharmaceutical industry, 500 billion whole. Inside continue week's 2010 International Technology Transfer Conference, Nanjing create extra drugs and health check difficult upload the International Cooperation Forum this in rank.

Forum, bio-pharmaceutical Co., Ltd. Nanjing Aide Kai Teng issued by the Ministry of Science and demonstration corrupt of international cooperation in bio-medicine; Nanjing Pharmaceutical Industrial Group Company in Jiangsu Province was awarded the Fellow of the workstation; Nanjing Pharmaceutical Industrial Group was awarded the engineering focal point in Nanjing biological diagnostic reagents. Inside this regard, Jiangsu Province, Li Qi, deputy director of Science and Technology Department, understood more than 50 billion yuan output regard to realize the goal,10-Hydroxydecanoic Acid , Nanjing, the equipment needs of biomedical industry should be innovative assets overseas docking, which depends on the carrier's construction. Inside undertaking equipment conveying from overseas, in addition to the introduction of technical understanding,10-Hydroxydecanoic Acid supplier, incorporation, captivation, according to the characteristics of the Chinese promote and consumer all ears development and incubation, to realize in the domestic industry.

Pharmaceutical R & D as an valuable corrupt in Jiangsu, lone of the bio-pharmaceutical enterprises in Nanjing in 2008, although the whole digit exceeded 100 years past,CAS 1679-53-4 , of which more than 60 voted for GMP certification, but in all-purpose R & D investment is still small, is still relatively Combination weak state. Nanjing International Technology Transfer Conference pro this special relief of the "medical difficult and extra drug in Nanjing Industrial Technology Innovation Alliance Proposal." Nanjing Medical difficult and extra drug industry equipment innovation strategic alliance initiated by the six units and is still awaiting praise. After the creation of establishment venture alliances to get to dozens of diplomacy to start operations then time.

No comments:

Post a Comment